Abstract Intraplatelet serotonin (5-HT) content was determined in 23 patients with type I (insulin-dependent) diabetes mellitus (IDDM), 23 patients with type II (non-insulin-dependent) diabetes mellitus (NIDDM), 29 patients with peripheral vascular disease (PVD) and 34 age-matched normal subjects. Baseline characteristics and risk factors were analysed from 9419 diabetic patients. 41 NIDDM patients and 31 non-diabetic subjects with PVD in the absence of rest pain or ulceration, defined by ankle-brachial index measurements and duplex scanning, were compared with 41 NIDDM and 31 euglycemic control subjects of comparable age and sex, without PVD. Peripheral arterial disease, also called PAD, occurs when blood vessels in the legs are narrowed or blocked by fatty deposits and blood flow to your feet and legs decreases. Conditions associated with PVD that affect the veins include deep vein thrombosis (DVT), varicose veins, and chronic venous insufficiency. This process may be caused by a combination of preventable risk factors such as high blood pressure, high cholesterol levels and smoking. Group A (31 patients without claudication) were not eligible to receive cilostazol whereas Group B (47 patients with claudication) received cilostazol administration for 24 weeks (100 mg orally twice daily).
T. Systolic is the first or higher value and diastolic is the second or lower value in the blood pressure reading. PVD is common among people with diabetes, particularly in women, who are nearly 8 times more likely to suffer from PVD than are women without diabetes. As shown in the meta-analysis, a complete PVD is required to significantly reduce the risk of PDR, while a partial PVD may worsen the prognosis. Obesity and lack of exercise can cause overall deterioration of the arterial system. Foot vibration perception had no predictive value on subsequent development of leg complications. The pain is most often felt in the calves of the legs, but it may also affect the thighs and buttocks.
It seems to be crucial to control these risk factors for the prevention of MA in NIDDM patients. This was fueled by an increase in the number of amputations occurring in individuals between the ages of 50 and 64 (16 percent to 22 percent) and a slight drop in individuals between the ages of 65 and 74 (35 percent to 31 percent).4 Further, there was an increase in the proportion of amputations among the high-risk cohort over time. These mammograms were reviewed retrospectively by the same group evaluating the screening mammograms.